ALXO – alx oncology holdings inc. (US:NASDAQ)
Stock Stats
News
ALX Oncology (ALXO) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $5.00 price target on the stock.
ALX Oncology (ALXO) had its "buy" rating reaffirmed by HC Wainwright. They now have a $4.00 price target on the stock.
ALX Oncology initiated with a Buy at UBS [Yahoo! Finance]
ALX Oncology (ALXO) is now covered by UBS Group AG. They set a "buy" rating and a $6.00 price target on the stock.
ALX Oncology Highlights $150M Raise, Evorpacept Breast Cancer Push and EGFR ADC ALX2004 Update [Yahoo! Finance]
Form 4 ALX ONCOLOGY HOLDINGS For: Mar 19 Filed by: Lettmann Jason
Form 4 ALX ONCOLOGY HOLDINGS For: Mar 19 Filed by: Pinto Shelly
Form 10-K ALX ONCOLOGY HOLDINGS For: Dec 31
Form 4 ALX ONCOLOGY HOLDINGS For: Mar 03 Filed by: Klencke Barbara
Form 3 ALX ONCOLOGY HOLDINGS For: Feb 25 Filed by: Klencke Barbara
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.